← Leaderboards
Protul Shrikant
Roswell Park Cancer Institute Corp
$4,542,208
Attributed
$5,373,770
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $964.4K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,373,770 · 3
By mechanism
R01$3,072,891 · 2
P50$2,300,879 · 1
Top collaborators
- Kunle O Odunsi5 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Walter J Storkus$19,974,413
- Christine B. Ambrosone$40,409,261
- Carl D Morrison$4,737,472
- Renier Joseph Brentjens$12,958,252
- Scott I. Abrams$11,133,748
Others in their field
Top investigators on “Memory”
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$159,370,162
- Richard Farnsworth · Battelle Memorial Institute$133,681,131
- Paula M Mabee · South Dakota Health Technologies Innovations Inc$133,681,131
- Christopher McKay · Battelle Memorial Institute$133,681,131
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Olaf Schneewind · University Of California Los Angeles$87,583,896
Research focus
MemoryIn VivoTumorBaseResponseAntigensReportingT-LymphocyteTumor AntigensImmunityMediatingMalignant NeoplasmsCd8b1 GeneCancer PatientOvarian NeoplasmRegimenEffector CellClinical TrialsDoseSafetyCellsMalignant Neoplasm Of OvaryImmuneImmunotherapy
Grant awards (15)
Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov$624,179
P50 · FY2017 · CA · contact PI
Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov$144,478
P50 · FY2016 · CA · contact PI
Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov$617,258
P50 · FY2015 · CA · contact PI
mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity$347,118
R01 · FY2015 · CA
Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov$586,921
P50 · FY2014 · CA · contact PI
mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity$332,586
R01 · FY2014 · CA
Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov$328,043
P50 · FY2013 · CA · contact PI
mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity$318,433
R01 · FY2013 · CA
mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity$334,591
R01 · FY2012 · CA
mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity$330,396
R01 · FY2011 · CA
Antigen-Specific CD8+ T Cell Responses by IL-21$284,569
R01 · FY2008 · CA · contact PI
Antigen-Specific CD8+ T Cell Responses by IL-21$280,810
R01 · FY2007 · CA · contact PI
Antigen-Specific CD8+ T Cell Responses by IL-21$285,439
R01 · FY2006 · CA · contact PI
Antigen-Specific CD8+ T Cell Responses by IL-21$288,570
R01 · FY2005 · CA
Antigen-Specific CD8+ T Cell Responses by IL-21$270,379
R01 · FY2004 · CA